WHO advises additional COVID shot for immunocompromised people
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- US stock futures steady after tech slump; investors focus on Middle East tensions
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- U.S. debt tops $40 trillion
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Marvell shares jump after giving Google warrants amid custom chip deal
Gavi’s Purchase of Additional Moderna’s (MRNA) mRNA-1273 Supply Supports Long-Term Outlook - Analyst
October 12, 2021 1:22 PM EDTEarlier today, Moderna, Inc. (Nasdaq: MRNA) today announced that Gavi, the Vaccine Alliance has exercised its option to purchase an additional 176.5 million doses of the Moderna COVID-19 vaccine for the COVAX Facility. Of these additional doses, 116.5 million doses are expected to be... More
COVAX Exercises Option to Purchase 176.5 Million Additional Doses of Moderna’s Moderna (MRNA) COVID-19 Vaccine
October 12, 2021 9:07 AM EDTModerna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that Gavi, the Vaccine Alliance has exercised its option to purchase an additional 176.5 million doses of the Moderna COVID-19 vaccine for the COVAX Facility. Of these additional doses, 116.5 million doses... More
No New Safety Concerns Have Been Identified After An J&J (JNJ) Booster Shot - Johnson & Johnson In FDA Presentation - Reuters
October 12, 2021 9:06 AM EDTNo New Safety Concerns Have Been Identified After An Johnson & Johnson (NYSE: JNJ) Booster Shot - Johnson & Johnson In FDA Presentation - Reuters
... More
